HOOKIPA Pharma Inc. (HOOK): Price and Financial Metrics


HOOKIPA Pharma Inc. (HOOK): $0.90

-0.05 (-5.25%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

HOOK Stock Price Chart Interactive Chart >

Price chart for HOOK

HOOK Price/Volume Stats

Current price $0.90 52-week high $3.25
Prev. close $0.95 52-week low $0.86
Day low $0.86 Volume 351,700
Day high $0.98 Avg. volume 2,274,213
50-day MA $1.21 Dividend yield N/A
200-day MA $1.54 Market Cap 49.24M

HOOKIPA Pharma Inc. (HOOK) Company Bio


HOOKIPA Pharma, Inc. engages in the development of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary its arenavirus platform that is designed to reprogram the body's immune system. Its product include VaxWace, a replication-deficient viral vector; and TheraT, a replication-attenuated viral vector, are designed to induce robust antigen specific CD8+ T cells and pathogen-neutralizing antibodies. The company was founded by Rolf Zinkernagel, Andreas Bergthaler, Lukas Flatz, and Daniel Pinschewer in 2011 and is headquartered in New York, NY.


HOOK Latest News Stream


Event/Time News Detail
Loading, please wait...

HOOK Latest Social Stream


Loading social stream, please wait...

View Full HOOK Social Stream

Latest HOOK News From Around the Web

Below are the latest news stories about HOOKIPA PHARMA INC that investors may wish to consider to help them evaluate HOOK as an investment opportunity.

Hookipa stock surges 46% on license deal with Roche for immunotherapy

Roche (OTCQX:RHHBY) (OTCQX:RHHBF) signed a license agreement with  Hookipa Pharma (NASDAQ:HOOK) to develop immunotherapy HB-700 for KRAS-mutated cancers and a second undisclosed novel arenaviral immunotherapy.

Under the agreement, Hookipa will receive $25M upfront. The Swiss pharma giant will have the option for an anothe...

Seeking Alpha | October 20, 2022

Read More 'HOOK' Stories Here

HOOK Price Returns

1-mo -30.23%
3-mo -29.13%
6-mo -47.98%
1-year -71.15%
3-year -89.04%
5-year N/A
YTD -61.37%
2021 -78.99%
2020 -9.32%
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7685 seconds.